Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases

BACKGROUND: Precise data about ATTR-CM incidence rates at national level are scarce. Consequently, this study aimed to estimate the annual incidence and survival of transthyretin amyloid cardiomyopathy (ATTR-CM) in France between 2011 and 2019 using real world data. We used the French nationwide exh...

Descripción completa

Detalles Bibliográficos
Autores principales: Damy, Thibaud, Bourel, Guillaume, Slama, Michel, Algalarrondo, Vincent, Lairez, Olivier, Fournier, Pauline, Costa, Jérôme, Pelcot, Françoise, Farrugia, Agnès, Zaleski, Isabelle Durand, Lilliu, Hervé, Rault, Caroline, Bartoli, Mathilde, Fievez, Stéphane, Granghaud, Anna, Rudant, Jeremie, Coste, Agathe, Cosson, Charlotte Noirot, Squara, Pierre-Alexandre, Narbeburu, Marion, De Neuville, Bertrand, Charron, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626733/
https://www.ncbi.nlm.nih.gov/pubmed/37926810
http://dx.doi.org/10.1186/s13023-023-02933-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626733/
https://www.ncbi.nlm.nih.gov/pubmed/37926810
http://dx.doi.org/10.1186/s13023-023-02933-w

Ejemplares similares